Randomized Assessment of Devices Used to Prevent Post-operative Hemorrhagic Risk in Endonasal Surgery (PRHEPOCE)
Otorhinolaryngologic Diseases
About this trial
This is an interventional prevention trial for Otorhinolaryngologic Diseases
Eligibility Criteria
Inclusion Criteria:
- endonasal surgery schedule
- Surgical indications:
hypertrophic rhinitis, repeated or chronic infections, extraction of foreign body, polyposes naso-sinusal, benign tumors limited to the nasal pit and in sine,
Exclusion Criteria:
- Pregnant Woman
- Disorder of the haemostasis known or disrupted preoperative biological balance assessment
- Use of treatment disrupting the blood coagulation (anti platelet, anti vitamin K, AINS)
- Unchecked HTA by the treatment and/or preoperative > mmHg 160/90
- Surgical Act including a septoplasty
- malignant tumoral surgical Indication, or mild overtaking the naso-sinusial system
- Dacryocystorhinostomy
Sites / Locations
Arms of the Study
Arm 1
Arm 2
Arm 3
Arm 4
Experimental
Experimental
Experimental
No Intervention
Surgiflo
Floseal
Algosteril
Abstention
Using Surgiflo® (Absorbable Gelatin Hemostatic) for the post-operative haemostasis in endonasal surgery.
Using Floseal® (Absorbable Gelatin Hemostatic) containing human thrombin for the post-operative haemostasis in endonasal surgery
Using Algosteril® (Hemostatic Sterile Wick) for the post-operative haemostasis in endonasal surgery
Not using device for the post-operative haemostasis in endonasal surgery